Medirom Healthcare Technologies Inc

Medirom Healthcare Technologies Inc(MRM)の株式分析

$0.284

-0.004 (-1.46%)終値時点

Loading chart…
高値
0.300
始値
0.300
出来高加重平均価格
0.29
出来高
13.98K
時価総額
18.55M
安値
0.280
売買代金
4.03K
EV/EBITDA(TTM)
0.00

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices.

medirom.co.jp

AI分析 of Medirom Healthcare Technologies Inc (MRM)

売り

Medirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.

バリュエーション指標

Medirom Healthcare Technologies Inc(MRM)の現在の予想PERは0.00で、5年平均は0.00です。

予想PER

大幅な割安
5年平均 P/E
0.00
現在のP/E
0.00
割高
0.00
割安
0.00

予想EV/EBITDA

適正
5年平均 EV/EBITDA
2.75
現在のEV/EBITDA
0.00
割高
7.92
割安
-2.42

予想PSR

適正
5年平均 P/S
0.04
現在のP/S
0.00
割高
0.14
割安
-0.05

Alphio AI による MRM の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%MRM

$1.40

シナリオ価格

基

基本

基本 · 50%MRM

$1.32

シナリオ価格

弱

弱気

弱気 · 25%MRM

$1.07

シナリオ価格

イベントタイムライン

2026-02-27 (ET)

08:10:00

Medirom Healthcare Signs Agreement with Tools for Humanity, Projects $39 Million Income Over Two Years

2025-12-29 (ET)

08:30:00

MEDIROM Collaborates with World Foundation to Deploy Proof of Human Technology in Japan

2025-12-26 (ET)

18:00:00

Medirom Healthcare Partners with World Foundation to Deploy Proof of Human Technology

2025-10-29 (ET)

10:25:23

Medirom Healthcare to Introduce New Treasury Strategy Utilizing Cryptocurrency

2025-10-28 (ET)

08:36:02

Medirom Healthcare reports that more than 10,000 individuals have obtained World IDs at various locations.

ニュース

MRM のよくある質問 — Alphio AI が回答

Medirom Healthcare Technologies Inc is a Japan-based holistic health services provider. The Company is a franchiser and operator of healthcare salons across Japan and is a preferred platform partner for large consumer brands, healthcare service providers and government entities. The Company mainly operates in two business segments. The Relaxation Salon Segment is engaged in the development of relaxation studios nationwide, centered on Re.Ra.Ku for the purpose of health management services. The Digital Preventative Healthcare Segment is involved in the sampling business, which includes brand promotion and consumer analysis for third party brands of corporate clients, government-sponsored specific health guidance program, utilizing internally-developed on-demand health monitoring smartphone application Lav, as well as MOTHER Tracker for fitness applications, and preventative healthcare services utilizing digital application and devices. It operates in the Consumer Non-Cyclicals sector.

Medirom Healthcare Technologies Inc (MRM) is not a good buy right now due to its extremely low RSI of 12.99, indicating it is oversold, and a staggering year-to-date change of -85.49%. The company's gross margin has improved to 99.65% in the last quarter, but the overall financial health is concerning with a debt-to-equity ratio of 174.83% and a current ratio of only 1.75, suggesting liquidity issues. The main risk is the significant decline in stock price, which has dropped 48.57% over the last 20 days, indicating a lack of investor confidence and potential further declines.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める